Henle et al., 1979 - Google Patents
The virus as the etiologic agent of infectious mononucleosisHenle et al., 1979
- Document ID
- 14839325171537867990
- Author
- Henle G
- Henle W
- Publication year
- Publication venue
- The Epstein-Barr Virus
External Links
Snippet
The world-wide distribution and high incidence of antibodies to the Epstein-Barr virus (EBV)(see Chap. 4) strongly suggested that the virus might be the unsuspected cause of a common disease, besides its association with two rare malignancies ie, Burkitt's lymphoma …
- 201000006747 infectious mononucleosis 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Henle et al. | The virus as the etiologic agent of infectious mononucleosis | |
| Blazar et al. | Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. | |
| Henle et al. | Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. | |
| Saemundsen et al. | Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia. | |
| Henle et al. | Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis | |
| Henle et al. | Epstein-barr virus specific diagnostic tests in infectous mononucleosis | |
| Lemon et al. | Replication of EBV in epithelial cells during infectious mononucleosis | |
| Jacobson et al. | Immunological findings in neurological diseases associated with antibodies to HTLV‐I: activated lymphocytes in tropical spastic paraparesis | |
| Henle et al. | Nasopharyngeal carcinoma: Significance of changes in Epstein‐Barr virus‐related antibody patterns following therapy | |
| Svedmyr et al. | Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis | |
| Epstein et al. | Introduction: discovery and general biology of the virus | |
| Pagano | Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation | |
| Sakamoto et al. | Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome | |
| de Schryver et al. | Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti‐MA) | |
| Hutt et al. | Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis | |
| Frank et al. | Epstein-Barr virus and nonhuman primates: natural and experimental infection | |
| The et al. | Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. | |
| Rickinson et al. | Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients. | |
| Falk et al. | Epstein‐Barr virus: transformation of non‐human primate lymphocytes in vitro | |
| Notkins | Infectious virus-antibody complexes: interaction with anti-immunoglobulins, complement, and rheumatoid factor | |
| ZIEGLER et al. | Epstein-Barr virus and human malignancy | |
| Andiman | The Epstein-Barr virus and EB virus infections in childhood | |
| Sixbey et al. | Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase | |
| Aya et al. | Early events in transformation of human cord leukocytes by Epstein‐Barr virus: induction of DNA synthesis, mitosis and the virus‐associated nuclear antigen synthesis | |
| Patarroyo et al. | Induction of the EBV cycle in B‐lymphocyte‐derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV‐related antigen (s) detected by the ADCC reaction |